CASI Pharmaceuticals, Inc. (CASI)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 32.03M |
| Enterprise Value | 22.50M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.94 |
| Price/Book (mrq) | 1.33 |
| Enterprise Value/Revenue | 0.66 |
| Enterprise Value/EBITDA | -1.04 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.33 |
| 52-Week Change 3 | -17.01% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 8.4800 |
| 52 Week Low 3 | 1.8500 |
| 50-Day Moving Average 3 | 3.6148 |
| 200-Day Moving Average 3 | 4.0819 |
Share Statistics
| Avg Vol (3 month) 3 | 203.19k |
| Avg Vol (10 day) 3 | 18.43k |
| Shares Outstanding 5 | 13.4M |
| Implied Shares Outstanding 6 | 13.4M |
| Float 8 | 5.44M |
| % Held by Insiders 1 | 47.45% |
| % Held by Institutions 1 | 8.45% |
| Shares Short (Apr 15, 2024) 4 | 62.51k |
| Short Ratio (Apr 15, 2024) 4 | 0.87 |
| Short % of Float (Apr 15, 2024) 4 | 0.71% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.47% |
| Shares Short (prior month Mar 15, 2024) 4 | 127.33k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Jun 02, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -79.51% |
| Operating Margin (ttm) | -50.32% |
Management Effectiveness
| Return on Assets (ttm) | -18.42% |
| Return on Equity (ttm) | -57.65% |
Income Statement
| Revenue (ttm) | 33.88M |
| Revenue Per Share (ttm) | 2.54 |
| Quarterly Revenue Growth (yoy) | -55.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -21.54M |
| Net Income Avi to Common (ttm) | -26.96M |
| Diluted EPS (ttm) | -2.0200 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 30.77M |
| Total Cash Per Share (mrq) | 2.37 |
| Total Debt (mrq) | 21.24M |
| Total Debt/Equity (mrq) | 87.89% |
| Current Ratio (mrq) | 3.55 |
| Book Value Per Share (mrq) | 1.81 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19.97M |
| Levered Free Cash Flow (ttm) | -13.71M |
© 2024 Yahoo. All rights reserved.